Page 3 - Torrent Pharmaceuticals

Glenmark, Torrent Pharma sign agreement to co-market diabetes drug in India

Glenmark launched Remogliflozin, indicated in the treatment of Type 2 Diabetes Mellitus in adults under the brand names Remo and Remozen

Overseas growth gets critical for Torrent Pharma as Unichem drags India biz

While it continues to work on integrating Unichem in its specialty model, Torrent Pharma will focus on overseas geographies like US, Brazil and Germany

How Torrent Pharma is integrating Unichem to boost its domestic business

The Ahmedabad-based pharma company plans to launch its first product from Bio-Pharm stable this quarter in the US; Unichem MR attrition rate has halved in the hope of a turnaround

Torrent Pharma puts US business on fast track: Acquires Bio-Pharm Inc

Acquisition of BPI helps the company to enter a limited competition category

Torrent's Unichem deal to add to its earnings after 3 years

For Unichem investors, larger gains will accrue if international business grows fast

Torrent Pharma to pay Rs 3,600 crore for Unichem's branded business

At Rs 3,600 crore, Torrent is paying 4.2 times its revenue for this acquisition

Torrent to buy Unichem's domestic biz for Rs 3,500 cr; announcement today

What makes Unichem lucrative to potential buyers is that only 10-12 per cent of its domestic drug portfolio comes under the National List of Essential Medicines

Torrent Pharma turns around Brazil business with 25% revenue jump

In 2015-16, the company's revenue in Brazil had declined 17% to Rs 506 crore

Torrent Pharma slips on disappointing Q2 results

The stock slipped 11% to Rs 1,400 on the BSE in intra-day trade

Torrent Pharma plans 50% hike in R&D spend, focuses on regulated mkts

The firm plans to launch 10 new products in the US in 2016

Torrent Pharma gains as Dahej plant receives EIR from USFDA

The stock moved higher by 4% to Rs 1,307 on the BSE.